Duration: CME/CE Points: Faculty:
CME : 5
IPCE : 5
MOC : 5
Contact Hours : 5

Oral Cancer and Complications of Cancer Therapies is organized by NetCE.

Release Date: Dec 01, 2017 
Expiration Date: Nov 30, 2020

This activity was planned by and for the healthcare team, and learners will receive 5 Interprofessional Continuing Education (IPCE) credit(s) for learning and change.

NetCE designates this enduring material for a maximum of 5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. NetCE designates this continuing education activity for 5 ANCC contact hour(s). NetCE designates this continuing education activity for 1 pharmacotherapeutic/pharmacology contact hour(s). NetCE designates this continuing education activity for 6 hours for Alabama nurses.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Completion of this course constitutes permission to share the completion data with ACCME.

Course Description :
Millions of people are diagnosed with a variety of malignant neoplastic lesions each year. Oral cancer, in which the primary malignancy arises within the oral cavity, is the 9th most common cancer in men and the 14th most common cancer in women. The common element among this diverse patient group are the problems encountered post-surgically when chemotherapy and or radiotherapy are used to destroy malignant cells, which can remain after the completion of surgery. Malignant lesions in the oral cavity are usually treated by surgical removal and several weeks of radiotherapy. The latter modality can cause severe changes in the mucosal tissues, bone, salivary glands, and the teeth, most of which are irreversible. Proper management before, during, and after both modes of therapy will have a positive impact on the quality of life and decrease the morbidity associated with these treatment regimens. This course will discuss the changes experienced within the oral environment during and after the treatment for oral and systemic cancers. Methods to mitigate these problems and to decrease the morbidity and the mortality which afflict these patients will be reviewed.

Learning Objectives: 
Upon completion of this course, you should be able to:
• Identify the most common etiologies of oral cancer and its incidence within the population.
• Review the basic histology of the oral mucosa and the changes that occur with premalignant and malignant lesions and their patterns of occurrence.
• Compare and contrast erythroplakic lesions and leukoplakic lesions.
• Distinguish among the varied diagnostic procedures for suspicious oral lesions and the classification and staging of those that are found to be malignant.
• Review the principles of and the complications from radiotherapy utilized postsurgically for patients with oral cancer.
• List dental procedures that should be completed before surgery and radiotherapy that can minimize oral complications after the completion of these treatment modalities.
• Explain the basic principles by which chemotherapeutic agents exert their cytotoxic effect.
• Discuss the serious chemotherapy-induced infections of oral origin that can be disseminated systemically.
• List other common oral effects of chemotherapy.

Target Audience

This course is designed for all physicians, including oncologists, surgeons, and radiologists, nurses, and speech, physical, and occupational therapists.


Activity Fee : USD $20.00



Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.